SCHEMBL14199537

SCHEMBL14199537

CS(=O)(=O)Nc1cc([C@@H](O)CNCCCCCCCCCN2CCC(OC(=O)Nc3ccc(F)cc3-c3ccc(O)c(Cl)c3)CC2)ccc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CHRM3 P20309 20/20 1.00
▸ ADRB2 P07550 17/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17101400 0.92 CHRM3 (1.00) CHRM3ADRB2
SCHEMBL14199539 0.92 CHRM3 (1.00) CHRM3ADRB2
SCHEMBL14199547 0.89 CHRM3 (0.79) CHRM3ADRB2
SCHEMBL14199548 0.88 CHRM3 (1.00) CHRM3ADRB2
SCHEMBL4016062 0.84 CHRM3 (0.73) CHRM3ADRB2
SCHEMBL4018488 0.84 CHRM3 (0.73) CHRM3ADRB2
SCHEMBL14199530 0.81 CHRM3 (0.79) CHRM3ADRB2
SCHEMBL4995831 0.79 CHRM3 (0.72) CHRM3ADRB2
SCHEMBL4995820 0.79 CHRM3 (0.72) CHRM3ADRB2
SCHEMBL4993872 0.79 CHRM3 (0.75) CHRM3ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090873-A1 Sulfonamide derivatives PFIZER INC. 2008-04-17 — — US disclosed
US-20080090873-A1 Sulfonamide derivatives PFIZER INC. 2008-04-17 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080090873-A1 Sulfonamide derivatives SULT2A1, SULT1A1, STS CHRM3 2453/4885ADRB2 2763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback